Effects of insulin and substances having insulin-like activity on adipose cells: sugar utilization, lipolysis, adenyl cyclase-cyclic AMP system and cyclic AMP-dependent protein kinase.
D000262:Adenylyl Cyclases; D000273:Adipose Tissue / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D000935:Antifungal Agents / Q000494:pharmacology; D001151:Arsenic / Q000494:pharmacology; D000242:Cyclic AMP; D004789:Enzyme Activation; D005227:Fatty Acids / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism*; D007328:Insulin / Q000494:pharmacology*; D007783:Lactones / Q000494:pharmacology; D008053:Lipid Mobilization / Q000187:drug effects*; D009284:Naphthols / Q000494:pharmacology; D009285:Naphthoquinones / Q000494:pharmacology; D010866:Natamycin / Q000494:pharmacology; D009761:Nystatin / Q000494:pharmacology; D010447:Peptide Hydrolases / Q000494:pharmacology; D010770:Phosphotransferases; D011506:Proteins; D011955:Receptors, Drug; D014634:Valinomycin / Q000494:pharmacology; D014812:Vitamin K / Q000494:pharmacology
D000935:Antifungal Agents; D005227:Fatty Acids; D007328:Insulin; D007783:Lactones; D009284:Naphthols; D009285:Naphthoquinones; D011506:Proteins; D011955:Receptors, Drug; D014812:Vitamin K; D009761:Nystatin; D014634:Valinomycin; D010866:Natamycin; D000242:Cyclic AMP; D010770:Phosphotransferases; D010447:Peptide Hydrolases; D000262:Adenylyl Cyclases; D005947:Glucose; D001151:Arsenic